# Plain Language Summary: Repealing the Trump Sick Tax Act

## What This Bill Does

This bill would undo two healthcare policy changes that were made in 2025. Specifically, it repeals changes to Medicaid cost-sharing requirements and removes an exclusion for orphan drugs (rare disease medications) from Medicare's drug price negotiation program. In simpler terms, the bill reverses recent decisions that made it harder or more expensive for certain patients to access medications and healthcare services.

## Who Would Be Affected

**Medicaid patients** would be the primary beneficiaries, as the bill would restore previous cost-sharing protections (meaning they would pay less out-of-pocket for medical care). **Patients with rare diseases** would also benefit, as orphan drug manufacturers would once again be subject to Medicare's drug price negotiation program, potentially lowering medication costs. Additionally, **state Medicaid programs** would see changes in how they manage costs and coverage.

## Key Provisions

The bill contains two main actions:

1. **Medicaid Cost-Sharing Repeal**: Reverses changes made to how much Medicaid patients must pay for services and restores the program to its previous structure
2. **Orphan Drug Exclusion Repeal**: Removes the exemption that prevented rare disease drugs from being included in Medicare's ability to negotiate lower drug prices
3. **Budget Rescission**: Cancels any federal funding that was appropriated for these previous changes